Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 Guidance

Go back to Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 Guidance

Charles River Laboratories (CRL) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus

February 13, 2019 7:09 AM EST

Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $1.49, $0.09 better than the analyst estimate of $1.40. Revenue for the quarter came in at $601.5 million versus the consensus estimate of $590.75 million.

James C. Foster, Chairman, President and Chief Executive Officer, said, We believe our strong financial... More